BPMA Benda Pharmaceutical, Inc featured news, full reports, and detailed charts
Benda Pharmaceutical, Inc (BPMA/BPMA.OB) Wrap Up:
Benda Pharmaceutical, Inc. identifies, discovers, develops, and manufactures conventional medications and traditional Chinese medicines for the treatment of common ailments and diseases. Its medicines are used for the treatment of common cold, diabetes, and cancer. The company’s products include Jixuening injection vial, a haemostatic that stops bleeding; Xujing injection vial, a haemostatic; Nokeqing injection vial, Suzheng-B injection vial, Vitamin B6 injection vial, Inosine injection vial medicines used in the treatment of hepatitis; Yidingshu injection vial to treat lack of Riboflavin; Shusai-A injection vial, an anti-inflammatory analgesic; Ribavirin injection vial, and Asarin API (1), ...www.bendapharma.com
400 Employees
Founded in 2005
Benda Pharmaceutical, Inc (BPMA:OTC Bulletin Board Market)
LAST $0.04 USD
CHANGE TODAY +0.01 33.33%
VOLUME 86.3K
As of 3:23 PM 11/20/09 All times are local (Market data by Reuters is delayed by at least 15 minutes).
Snapshot of Benda Pharmaceutical, Inc (BPMA)
|
OPEN
$0.03
|
PREVIOUS CLOSE
$0.03
|
|
|
DAY HIGH
$0.04
|
DAY LOW
$0.03
|
|
|
52 WEEK HIGH
10/20/09 - $0.10
|
52 WEEK LOW
07/24/09 - $0.0050
|
|
|
MARKET CAP
4.2M
|
AVERAGE VOLUME 3 mo
73.1K
|
|
|
DILUTED EPS TTM
--
|
SHARES OUTSTANDING
105.2M
|
|
|
BPMA Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
BPMA Top Compensated Officers
Mr. Yiqing Wan
Co-Founder, Chairman, Chief Executive Officer...
Age: 46
Total Annual Compensation: $160.0K
Ms. Xu Wei
Co-Founder and Vice President of Operations
Age: 46
Total Annual Compensation: $100.0K
Mr. Long Hui
Vice President of Technology
Age: 48
Total Annual Compensation: $6.2K
Mr. Daping Gu
Vice President of Marketing
Age: 61
Total Annual Compensation: $6.0K
Mr. Jingbo Wu
Vice President
Age: 47
Total Annual Compensation: $6.0K
Executives, Board Directors
Compensation as of Fiscal Year 2008.
Key developments for Benda Pharmaceutical, Inc (BPMA)
Benda Pharmaceutical, Inc announced delayed 10-Q filing
11/16/2009
On 11/16/2009, Benda Pharmaceutical, Inc announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Benda Pharmaceutical Inc. Announces Resignation of Eric Yu as Chief Financial Officer and Executive Director
09/22/2009
Benda Pharmaceutical Inc. announced that Eric Yu submitted a letter of resignation notifying that he resigned from the position of Chief Financial Officer and Executive Director, effective September 21, 2009. Mr. Yu's resignation was due to personal reasons and not the result of any disagreement with the company or any officers or directors of the company.
Benda Pharmaceutical, Inc. Announces New Address
08/19/2009
Benda Pharmaceutical, Inc. announced that the new address of the company's headquarters to be used for all correspondence is Taibei Mingju, 4th Floor, 6 Taibei Road, Wuhan, Hubei Province, 430015, PRC.
BPMA Competitors
| Company | Last | Change | |
| No competitor information is available for BPMA. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | BPMA | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 0.2x |
|
| Price/Book | 0.3x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | NM | Not Meaningful |
|
BPMA |
||
|
BPMA transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent News About Benda Pharmaceutical, Inc
Would you like to leave a comment about Benda Pharmaceutical, Inc BPMA/BPMA.OB
Find out what social network information about Benda Pharmaceutical, Inc are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides Benda Pharmaceutical, Inc there is more great information available at Realpennies.com